How to buy Atossa Genetics stock (ATOS)

Atossa Genetics is a biotechnology business based in the US. Atossa Genetics shares (ATOS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.96 – a decrease of 13.96% over the previous week. Atossa Genetics employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Atossa Genetics stock

Buy Atossa Genetics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Atossa Genetics stock price (NASDAQ: ATOS)

Use our graph to track the performance of ATOS stocks over time.

Atossa Genetics shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$0.96
52-week range	$0.73 - $2.31
50-day moving average more info button	$1.34
200-day moving average more info button	$1.40
Wall St. target price	$6.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.21

Is it a good time to buy Atossa Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Atossa Genetics price performance over time

Historical closes compared with the close of $0.9637 from 2024-12-20

1 week (2024-12-13)	-13.96%
1 month (2024-11-22)	-21.01%
3 months (2024-09-20)	-33.99%
6 months (2024-06-21)	-14.72%

1 year (2023-12-22)	23.58%
2 years (2022-12-21)	68.48%
3 years (2021-12-21)	1.86
5 years (2019-12-20)	1.54

Atossa Genetics financials

Gross profit TTM	$0
Return on assets TTM	-20.35%
Return on equity TTM	-31.3%
Profit margin	0%
Book value	$0.59
Market Capitalization more info button	$124.5 million

TTM: trailing 12 months

Atossa Genetics share dividends

We're not expecting Atossa Genetics to pay a dividend over the next 12 months.

Have Atossa Genetics's shares ever split?

Atossa Genetics's shares were split on a 1:12 basis on 19 April 2018 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Atossa Genetics shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Atossa Genetics shares which in turn could have impacted Atossa Genetics's share price.

Atossa Genetics share price volatility

Over the last 12 months, Atossa Genetics's shares have ranged in value from as little as $0.73 up to $2.31. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atossa Genetics's is 1.232. This would suggest that Atossa Genetics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Atossa Genetics overview

Atossa Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020.

Frequently asked questions

null
What percentage of Atossa Genetics is owned by insiders or institutions?
Currently 0.058% of Atossa Genetics shares are held by insiders and 28.164% by institutions. How many people work for Atossa Genetics?
Latest data suggests 12 work at Atossa Genetics. When does the fiscal year end for Atossa Genetics?
Atossa Genetics's fiscal year ends in December. Where is Atossa Genetics based?
Atossa Genetics's address is: 107 Spring Street, Seattle, WA, United States, 98104 What is Atossa Genetics's ISIN number?
Atossa Genetics's international securities identification number is: US04962H5063 What is Atossa Genetics's CUSIP number?
Atossa Genetics's Committee on Uniform Securities Identification Procedures number is: 04962H506